214 related articles for article (PubMed ID: 35814340)
1. Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.
Russell MD; Rutherford AI; Ellis B; Norton S; Douiri A; Gulliford MC; Cope AP; Galloway JB
Lancet Reg Health Eur; 2022 Jul; 18():100416. PubMed ID: 35814340
[TBL] [Abstract][Full Text] [Related]
2. Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England.
Russell MD; Roddy E; Rutherford AI; Ellis B; Norton S; Douiri A; Gulliford MC; Cope AP; Galloway JB
Rheumatology (Oxford); 2023 Jul; 62(7):2426-2434. PubMed ID: 36355461
[TBL] [Abstract][Full Text] [Related]
3. Cohort study investigating gout flares and management in UK general practice.
Finnikin S; Mallen CD; Roddy E
BMC Prim Care; 2023 Nov; 24(1):246. PubMed ID: 37993770
[TBL] [Abstract][Full Text] [Related]
4. Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares.
Russell MD; Ameyaw-Kyeremeh L; Dell'Accio F; Lapham H; Head N; Stovin C; Patel V; Clarke BD; Nagra D; Alveyn E; Adas MA; Bechman K; de la Puente MA; Ellis B; Byrne C; Patel R; Rutherford AI; Cantle F; Norton S; Roddy E; Hudson J; Cope AP; Galloway JB
Rheumatology (Oxford); 2023 Oct; ():. PubMed ID: 37929968
[TBL] [Abstract][Full Text] [Related]
5. Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
Peeters IR; den Broeder AA; Taylor WJ; den Broeder N; Flendrie M; van Herwaarden N
Trials; 2023 Apr; 24(1):282. PubMed ID: 37072799
[TBL] [Abstract][Full Text] [Related]
6. Management of gout by UK rheumatologists: a British Society for Rheumatology national audit.
Roddy E; Packham J; Obrenovic K; Rivett A; Ledingham JM
Rheumatology (Oxford); 2018 May; 57(5):826-830. PubMed ID: 29447370
[TBL] [Abstract][Full Text] [Related]
7. Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial.
Mu Z; Wang W; Wang J; Lv W; Chen Y; Wang F; Yu X; Wang Y; Cheng B; Wang Z
Clin Rheumatol; 2019 Dec; 38(12):3511-3519. PubMed ID: 31410659
[TBL] [Abstract][Full Text] [Related]
8. Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink.
Kiddle SJ; Sundell KA; Perl S; Nolan S; Bjursell M
Clin Cardiol; 2024 Jun; 47(6):e24297. PubMed ID: 38873862
[TBL] [Abstract][Full Text] [Related]
9. Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY.
Russell MD; Massey J; Roddy E; MacKenna B; Bacon S; Goldacre B; Andrews CD; Hickman G; Mehrkar A; Mahto A; Rutherford AI; Patel S; Adas MA; Alveyn E; Nagra D; Bechman K; Ledingham JM; Hudson J; Norton S; Cope AP; Galloway JB
Lancet Rheumatol; 2023 Oct; 5(10):e622-e632. PubMed ID: 38251486
[TBL] [Abstract][Full Text] [Related]
10. [Gout management: an update].
Ankli B; Krähenbühl S
Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
[TBL] [Abstract][Full Text] [Related]
11. Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis.
Son CN; Stewart S; Su I; Mihov B; Gamble G; Dalbeth N
Semin Arthritis Rheum; 2021 Aug; 51(4):677-684. PubMed ID: 34139520
[TBL] [Abstract][Full Text] [Related]
12. Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.
Dalbeth N; House ME; Horne A; Petrie KJ; McQueen FM; Taylor WJ
BMC Musculoskelet Disord; 2012 Sep; 13():174. PubMed ID: 22978848
[TBL] [Abstract][Full Text] [Related]
13. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
Roddy E; Zhang W; Doherty M
Ann Rheum Dis; 2007 Oct; 66(10):1311-5. PubMed ID: 17504843
[TBL] [Abstract][Full Text] [Related]
14. Adherence and Treat-to-Target Benchmarks in Older Adults With Gout Initiating Urate-Lowering Therapy in Ontario, Canada: A Population-Based Study.
Kwok TSH; Kuriya B; Hawker G; Eder L; Li P; Choy G; Widdifield J
Arthritis Care Res (Hoboken); 2024 Jun; ():. PubMed ID: 38831665
[TBL] [Abstract][Full Text] [Related]
15. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.
Pisaniello HL; Lester S; Gonzalez-Chica D; Stocks N; Longo M; Sharplin GR; Dal Grande E; Gill TK; Whittle SL; Hill CL
Arthritis Res Ther; 2018 Jul; 20(1):143. PubMed ID: 29996922
[TBL] [Abstract][Full Text] [Related]
16. Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research.
Feng X; Li Y; Gao W
Joint Bone Spine; 2015 Dec; 82(6):428-31. PubMed ID: 26456042
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study.
Kielstein JT; Heisterkamp M; Jing J; Nadal J; Schmid M; Kronenberg F; Busch M; Sommerer C; Lorenzen JM; Eckardt KU; Köttgen A;
Clin Kidney J; 2021 Jan; 14(1):277-283. PubMed ID: 33564429
[TBL] [Abstract][Full Text] [Related]
18. An update on the management of gout.
Drug Ther Bull; 2018 Jan; 56(1):9-12. PubMed ID: 29326278
[TBL] [Abstract][Full Text] [Related]
19. 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.
Uhlig T; Karoliussen LF; Sexton J; Borgen T; Haavardsholm EA; Kvien TK; Hammer HB
RMD Open; 2021 Mar; 7(1):. PubMed ID: 33782189
[TBL] [Abstract][Full Text] [Related]
20. Current management of gout: practical messages from 2016 EULAR guidelines.
Nuki G; Doherty M; Richette P
Pol Arch Intern Med; 2017 Apr; 127(4):267-277. PubMed ID: 28430170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
